Heineken document reveals worries over weight-loss drugs and beer sales

Heineken has warned UK pubs about the increasing impact of weight-loss drugs on beer sales. These medications may reduce consumers' desire to drink, leading to declines in bar revenue. Heineken suggests that bars offer half-pints and low-alcohol options to adapt. Research indicates that users of these drugs are spending less on alcohol. The broader alcohol industry is facing challenges as consumer behavior shifts amid health trends.